KATHLEEN SWILIK: Open Payments
NPI 1215549753 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$822 in 42 payments from 20 companies in 2025. Trend: 2023 $785 · 2024 $777 · 2025 $822
Food & beverage: $822
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $112 |
| Biogen, Inc. | 3 | $88 |
| ABBVIE INC. | 5 | $86 |
| Teva Pharmaceuticals USA, Inc. | 4 | $76 |
| PFIZER INC. | 3 | $46 |
| Axsome Therapeutics, Inc. | 3 | $43 |
| Averitas Pharma Inc. | 2 | $43 |
| Valinor Pharma, LLC | 3 | $42 |
| Azurity Pharmaceuticals, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
Products named: JOURNAVX, TYSABRI, AUSTEDO XR, QULIPTA, NURTEC ODT, REXULTI, QUTENZA, MOVANTIK.
Industry payments across IN — which companies pay providers there.
